DeepMed Research

Integra LifeSciences Corporation

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

CERTAS Programmable Valve Registry

Completed

Conditions: Hydrocephalus
NPH (Normal Pressure Hydrocephalus)
IIH - Idiopathic Intracranial Hypertension

Interventions: Device: CODMAN CERTAS Programmable Valves

First Posted Date: 2019-12-20

Last Posted Date: 2022-01-26

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 35

Registration Number: NCT04207229

Locations: 🇳🇱
Erasmus University Medical Center, Rotterdam, Netherlands
🇩🇪
UniversitätsKlinikum Essen, Essen, Germany
🇩🇪
Freiburg University Hospital, Freiburg, Germany

and more 5 locations

The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series

Terminated

Conditions: Pilonidal Disease

First Posted Date: 2019-08-01

Last Posted Date: 2021-04-20

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 2

Registration Number: NCT04041037

Locations: 🇺🇸
AdventHealth Tampa, Tampa, Florida, United States

Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)

Completed

Conditions: Carotid Artery Stenosis

Interventions: Device: Sundt carotid shunt

First Posted Date: 2019-01-25

Last Posted Date: 2022-01-14

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 100

Registration Number: NCT03816202

Locations: 🇺🇸
Research Institute of Deaconess Clinic, Newburgh, Indiana, United States
🇺🇸
The Mount Sinai Medical Center, New York, New York, United States
🇺🇸
Hackensack Meridian Health, Hackensack, New Jersey, United States

Cytal® Wound Matrix and MicroMatrix® Wound Study

Terminated

Conditions: Wounds

Interventions: Device: ACell Arm

First Posted Date: 2018-08-16

Last Posted Date: 2021-05-11

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 37

Registration Number: NCT03632954

Locations: 🇺🇸
NYU Winthrop Hospital, Long Island City, New York, United States

Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care

Not Applicable

Terminated

Conditions: Diabetic Foot
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Diabetes

Interventions: Device: Cytal Wound Matrix 1-Layer
Other: Standard of Care (SOC)

First Posted Date: 2018-08-13

Last Posted Date: 2021-08-25

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 15

Registration Number: NCT03626623

Locations: 🇺🇸
Limb Preservation Platform, Inc., Fresno, California, United States
🇺🇸
Louisiana State University Health Science Center (LSUHSC), New Orleans, Louisiana, United States
🇺🇸
MedStar Health Research Institute, Hyattsville, Maryland, United States

A Study to Evaluate the Efficacy of Cytal® Burn Matrix in the Management of Partial-Thickness Burns to the Hand

Not Applicable

Withdrawn

Conditions: Partial Thickness Burn of Hand

Interventions: Device: EZ-Derm® Porcine Xenograft
Device: Cytal® Burn Matrix

First Posted Date: 2018-07-26

Last Posted Date: 2021-04-01

Lead Sponsor: Integra LifeSciences Corporation

Registration Number: NCT03598023

AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers

Not Applicable

Completed

Conditions: Diabetic Foot Ulcer

Interventions: Device: A Marketed Comparator
Other: Standard of Care
Other: AMNIOEXCEL Plus Amniotic Membrane

First Posted Date: 2018-06-06

Last Posted Date: 2020-07-20

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 116

Registration Number: NCT03547635

Locations: 🇺🇸
Georgia 1, Gainesville, Georgia, United States
🇺🇸
Illinois 1, Springfield, Illinois, United States
🇺🇸
New Jersey 1, Toms River, New Jersey, United States

and more 4 locations

Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries

Not Applicable

Completed

Conditions: Pressure Ulcer, Stage IV
Pressure Ulcer
Pressure Ulcers Stage III

Interventions: Device: MicroMatrix® and Cytal™ Wound Matrix 2-Layer plus NPWT
Device: MicroMatrix® and Cytal™ Wound Matrix 2-Layer
Device: Negative Pressure Wound Therapy

First Posted Date: 2017-09-14

Last Posted Date: 2021-04-20

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 60

Registration Number: NCT03283787

Locations: 🇺🇸
Saint Vincent's Medical Center, Jacksonville, Florida, United States

PriMatrix for the Management of Diabetic Foot Ulcers

Not Applicable

Completed

Conditions: Diabetic Foot Ulcer

Interventions: Device: PriMatrix Dermal Repair Scaffold
Device: Secondary Dressings
Device: Offloading device

First Posted Date: 2017-01-05

Last Posted Date: 2022-04-29

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 226

Registration Number: NCT03010319

Locations: 🇺🇸
Wound Care of Tulsa, Tulsa, Oklahoma, United States
🇺🇸
LA Podiatry Group, West Palm Beach, Florida, United States
🇺🇸
JPS Health Network, Fort Worth, Texas, United States

and more 14 locations

MEDIHONEY® Gel Versus Collagenase for Wound Debridement

Not Applicable

Terminated

Conditions: Wounds
Ulcer

Interventions: Device: Active Leptospermum Honey (Medihoney)
Drug: Collagenase

First Posted Date: 2015-06-26

Last Posted Date: 2017-12-02

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 10

Registration Number: NCT02482948

Locations: 🇺🇸
Innovative Healing Systems, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy